Cangene Corporation announced that its board of directors has unanimously appointed John A. Sedor as president and chief executive officer.
News & Media
IMRIS Inc.announced that it has received a Health Canada medical device license for AccuTrack™ the Company’s 3D image guidance tool for use in IMRIS neurosurgery suites.
A new study, in partnership between The Richardson Centre for Functional Foods and Nutraceuticals and St. Luke's-Roosevelt Hospital, has found a link between weight gain and sleep deprivation.
The first Canadian installation is being tested in Barrie, Ont. The second and third Canadian sales may happen before the end of the year.
The Canadian Innovation Commercialization Program (CICP) is a new, $40 million procurement program, launched as part of the Government of Canada’s commitment to promote Canada’s economic growth as announced in Budget 2010.
Two Winnipeg biotech firms braved the challenging capital markets this week in attempts to raise important development funds.
The Canada-Israel Industrial R&D Foundation (CIIRDF) is pleased to invite Canadian and Israeli companies to submit new joint R&D project proposals for funding.
DiaMedica is pleased to announce the completion today of its previously announced short form prospectus offering.
Medicure Inc. is pleased to announce that, following a comprehensive strategic review and formal process, as first announced in the press release of January 13, 2010, the Company has completed the following transactions:
Valeant Pharmaceuticals announced plans Friday to shift its U.S. production to Quebec as it continued a shopping spree to become the world's largest dermatological treatment company
The Honourable Rona Ambrose, Minister of Public Works and Government Services and Minister for Status of Women, is pleased to announce that the Government of Canada is once again accepting applications from local businesses to help kickstart their innovat
Medicure International and Iroko Cardio Sign an Agreement for the Advancement of AGGRASTAT® Worldwide
Medicure Inc. announced that its subsidiary, Medicure International, Inc. and Iroko Cardio, LLC have entered into an agreement to advance AGGRASTAT® (tirofiban HCl) in each of their respective territories
Monteris Medical Inc. announced that it has concluded an $8.6 million financing led by the Business Development Bank of Canada.
Manitoba's Composites Innovation Centre (CIC) and Minnesota's Chopper College have partnered to create a commercial-scale, eco-friendly, high performance motorcycle--powered by biofuels and enhanced with bio-composite parts developed by the CIC.
Cangene announced that the Biomedical Advanced Research and Development Authority will exercise options under a botulism antitoxin supply contract, which are expected to generate approximately US$61 million in additional revenue for Cangene over the next
The LSAM job posting page connects qualified candidates eager to succeed in the life sciences to member organizations with open positions.
Province, University of Manitoba, GlaxoSmithKline Establish Endowed Research Chair to Study Infectious Disease
The creation of Manitoba’s first-ever research chair in the immunobiology of infectious disease at the University of Manitoba will further develop the province’s internationally-recognized expertise in infectious disease research.
Kane Biotech Inc. has won a significant new contract with a U.S. army medical research facility that will leverage other development opportunities for the firm.
New Program to Promote Business, Economic Growth: Province Will Invest $30 Million Over Five Years --Selinger
A new, $30-million Commercialization Support for Business Program has been established to promote and support entrepreneurism, commercialization and business development, Premier Greg Selinger announced
The Province of Manitoba and Manitoba Hydro are entering an agreement with Nissan Canada to work together on initiatives that will help advance the use of plug-in electric vehicles in the province, Innovation, Energy and Mines Minister Dave Chomiak announ
Valeant agreed to buy AB Sanitas for about 314 million euros ($442 million) to add dermatology drugs in eastern and central Europe